Pinnacle Summer Investments’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Pinnacle Summer Investments’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-246	Closed	-$15K	–	1034
2015 Q3	$15K	Buy	+246	New	+$19.4K	﹤0.01%	676
2015 Q2	–	Sell	-318	Closed	-$24K	–	964
2015 Q1	$24K	Hold	318	–	–	﹤0.01%	625
2014 Q4	$20K	Hold	318	–	–	﹤0.01%	665
2014 Q3	$17K	Hold	318	–	–	﹤0.01%	723
2014 Q2	$16K	Hold	318	–	–	﹤0.01%	694
2014 Q1	$14K	Hold	318	–	–	﹤0.01%	663
2013 Q4	$14K	Hold	318	–	–	﹤0.01%	679
2013 Q3	$14K	Hold	318	–	–	﹤0.01%	619
2013 Q2	$11K	Buy	+318	New	+$11.2K	﹤0.01%	606

Other funds holding XBI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Pinnacle Summer Investments's XBI Position: Q4 2015 in Review

Pinnacle Summer Investments sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2015, closing a stake of 246 shares — an estimated $15K sold.

Pinnacle Summer Investments first reported a position in XBI in Q2 2013 and held it in 9 quarters. The position peaked at $24K in Q1 2015. 199 funds tracked by Wall St. Rank hold XBI as of Q4 2015.

Pinnacle Summer Investments reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2015 after selling out during the quarter.
Pinnacle Summer Investments sold 246 State Street SPDR S&P Biotech ETF shares in Q4 2015, an estimated $15K.
Pinnacle Summer Investments first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and held it in 9 quarters.
Pinnacle Summer Investments's State Street SPDR S&P Biotech ETF position peaked at $24K in Q1 2015.
199 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2015.

Based on Pinnacle Summer Investments's 13F filing for Q4 2015, filed 16 Feb 2016.